New Alzheimer's Blood Tests Offer Early Detection, Raise Ethical Questions

New research highlights a novel blood test capable of predicting early dementia risk by identifying elevated p-tau217 biomarker levels up to five years in advance. While these new Alzheimer's blood tests are becoming easier to access, their availability also prompts important questions about whether individuals truly want to know their risk and the broader implications of such early detection.